Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.

Source:http://linkedlifedata.com/resource/pubmed/id/2951438

J. Immunol. 1987 Apr 1 138 7 2359-65

Download in:

View as

General Info

PMID
2951438